Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Tian, Yueru ^a   Li, Tianming ^b   Zhu, Yuanjun ^a   Wang, Bei ^a   Zou, Xue ^c   Li, Min ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Biofilm production; Cell wall thickness; cfr; Linezolid resistance; Mutations of 23S rRNA and ribosomal proteins

Indexed keywords

AMIKACIN; AMPICILLIN; ARGININE; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; CYSTEINE; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; RNA 23S; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CFR PROTEIN, STAPHYLOCOCCUS AUREUS; OXAZOLIDINONE DERIVATIVE; RIBOSOME PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOFILM; CFR GENE; CHINA; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENE DOSAGE; GENE MUTATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORF1 GENE; PREVALENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL; CELL WALL; DRUG EFFECTS; ENTEROCOCCUS; GENETICS; GRAM POSITIVE INFECTION; HORIZONTAL GENE TRANSFER; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POINT MUTATION; STAPHYLOCOCCUS; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL WALL; CHINA; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GENE TRANSFER, HORIZONTAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; OXAZOLIDINONES; POINT MUTATION; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S; STAPHYLOCOCCUS;

EID: 84930208994     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-014-0292-5     Document Type: Article

References (34)

1. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL: The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 1998, 42:3251-3255.
2. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C: Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001, 358:207-208.
3. Wilson P, Andrews JA, Charlesworth R, Walesby R, Singer M: Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrobial Chemotherapy 2003, 51:186-188.
4. Meka VG, Pillai SK, Sakoulas G, Wennersten C, Venkataraman L: Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23SrRNA gene and loss of a single copy of rRNA. J Infect Dis 2004, 190:311-317.
5. Schwarz S, Werckenthin C, Kehrenberg C: Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri. Antimicrob Agents Chemother 2000, 44:2530-2533.
6. Livermore DM, Warner M, Mushtaq S, North S, Woodford N: In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and-susceptible staphylococci and enterococci. Antimicrob Agents Chemother 2007, 51:1112-1114.
7. Livermore DM, Mushtaq S, Warner M, Woodford N: Activity of oxazolidinone TR-700 against linezolid-susceptible and-resistant staphylococci and enterococci. J Antimicrobial Chemotherapy 2009, 63:713-715.
8. Cai JC, Hu YY, Zhang R, Zhou HW, Chen GX: Linezolid-resistant clinical isolates of meticillin-resistant coagulase-negative staphylococci and Enterococcus faecium from China. J Med Microbiol 2012, 61:1568-1573.
9. Lincopan N, de Almeida LM, de Araújo MR E, Mamizuka EM: Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene. Int J Antimicrob Agents 2009, 34:281-282.
10. Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B: A new mechanism for chloramphenicol, forfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol 2005, 57:1064-1073.
11. Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B: The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 2006, 50:2500-2505.
12. Locke JB, Hilgers M, Shaw KJ: Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin. Antimicrob Agents Chemother 2009, 53:5275-5278.
13. Locke JB, Hilgers M, Shaw KJ: Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones Linezolid and Torezolid(TR-700). Antimicrob Agents Chemother 2009, 53:5265-5274.
14. Almeida LM, Araújo MR, Sacramento AG, Pavez M, Souza AG: Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations. Antimicrob Agents Chemother 2013, 57:4082-4083.
15. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
16. Louis BR, x MD: Antimicrobial resistance in Gram-positive bacteria. Am J Med 2006, 119:11-19.
17. Wang Y, Zhang W, Wang J, Wu C, Shen Z: Distribution of the multidrug resistance gene cfr in Staphylococcus species isolates from swine farms in China. Antimicrob Agents Chemother 2012, 56:1485-1490.
18. Yang XJ, Chen Y, Yang Q, Qu TT, Liu LL: Emergence of cfr-harboring coagulase-negative Staphylococci among patients received linezolid therapy in two hospitals of China. J Med Microbiol 2013, 62:845-850.
19. Chen H, Wu W, Ni M, Liu Y, Zhang J: Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms. Int J Antimicrob Agents 2013, 42:317-321.
20. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informational Supplement M100-S23. Wayne, PA, USA: CLSI; 2013.
21. Enright MC, Spratt BG: Multilocus sequence typing. Trends Microbiol 1999, 7:482-487.
22. Nallapareddy SR, Duh RW, Singh KV, Murray BE: Molecular typing of selected Enterococcus faecalis isolates: pilot study using multilocus sequence typing and pulsed-field gel electrophoresis. J Clin Microbiol 2002, 40:868-876.
23. Homan WL, Tribe D, Poznanski S, Li M, Hogg G: Multilocus sequence typing scheme for Enterococcus faecium. J ClinMicrobiol 2002, 40:1963-1971.
24. Aanensen DM, Spratt BG: The multilocus sequence typing network: mlst. net. Nucleic Acids Res 2005, 33:728-733.
25. Arias CA, Panesso D, Singh KV, Rice LB, Murray BE: Cotransfer of antibiotic resistance genes and a hylEfm-containing virulence plasmid in Enterococcus faecium. Antimicrob Agents Chemother 2009, 10:4240-4246.
26. Mendes RE, Deshpande LM, Farrell DJ, Spanu T, Fadda G: Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J Antimicrobial Chemotherapy 2010, 65:2329-2335.
27. Toh SM, Xiong L, Arias CA, Villegas MV, Lolans K: Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol 2007, 64:1506-1514.
28. Besier S, Ludwig A, Zander J, Brade V, Wichelhaus TA: Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother 2008, 52:1570-1572.
29. Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB: Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002, 10:3334-3336.
30. Schneider CA, Rasband WS, Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012, 9:671-675.
31. Román F, Roldán C, Trincado P, Ballesteros C, Carazo C: Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain. Antimicrob Agents Chemother 2013, 57:2428-2429.
32. Mendes RE, Hogan PA, Streit JM, Jones RN, Flamm RK: Zyvox(R) Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years (2004-12). J Antimicrobial Chemotherapy 2014, 69:1582-1588.
33. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM: The emerging problem of linezolid-resistant Staphylococcus. J Antimicrobial Chemotherapy 2013, 68:4-11.
34. Flamm RK, Mendes RE, Ross JE, Sader HS, Jones RN: An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011. Diagn Microbiol Infect Dis 2013, 76:206-213.